Monoclonal antibodies - a revolutionary therapy in multiple sclerosis.

Published in: Neurologia i neurochirurgia polska (2020)

There is still a need for personalised medicines, with a specific target, which should have fewer adverse effects and drug interactions.

Keyphrases